Europe: Where is the drug discovery innovation?
Drug Discovery World
MAY 6, 2024
The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates. This enabled the Basel start-up ecosystem to grow considerably and consistently, with a strong acceleration in the last five to 10 years.
Let's personalize your content